Skip to main content
. 2022 Oct 1;13(5):1523–1531. doi: 10.14336/AD.2022.0205

Table 2A.

Demographic characteristics and patient outcomes of participants offered treatment with bamlanivimab.

PARTICIPANTS OFFERED TREATMENT
Characteristic Offered Treatment Hospitalizations Deaths
n = 61 n = 13 n = 9
Sex n % n % n %
Male 21 34.43 4 30.77 3 33.33
Female 40 65.57 9 69.23 6 66.67
Age
Mean 77.45 84.00 81.22
Median 76.00 86.00 80.00
< 65 10 16.39 1 7.69 0 0
65 - 74 19 31.15 2 15.38 4 44.44
75 - 84 13 21.31 3 23.08 2 22.22
85 - 94 14 22.95 4 30.77 2 22.22
≥ 95 5 8.20 3 23.08 1 11.11
Ethnicity
White 52 85.25 11 84.62 9 100
African American 9 14.75 2 15.38 0 0
Other 0 0 0 0 0 0